Works about ALISKIREN

Results: 217

Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure.

Published in:

Indian Journal of Pharmacology, 2015, v. 47, n. 1, p. 80, doi. 10.4103/0253-7613.150351

By:

Soni, Hitesh M.;
Patel, Praful P.;
Patel, Savan;
Rath, Akshyaya C.;
Acharya, Aviseka;
Trivedi, Harshkant D.;
Jain, Mukul R.

Publication type:

Article

Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation.

Published in:

Heart & Vessels, 2017, v. 32, n. 1, p. 90, doi. 10.1007/s00380-016-0874-2

By:

Satoh, Akira;
Niwano, Shinichi;
Niwano, Hiroe;
Kishihara, Jun;
Aoyama, Yuya;
Oikawa, Jun;
Fukaya, Hidehira;
Tamaki, Hideaki;
Ako, Junya

Publication type:

Article

Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.

Published in:

Heart & Vessels, 2013, v. 28, n. 4, p. 442, doi. 10.1007/s00380-012-0260-7

By:

Abe, Masanori;
Suzuki, Hiroko;
Okada, Kazuyoshi;
Maruyama, Noriaki;
Inoshita, Atsushi;
Baba, Seishiro;
Takashima, Hiroyuki;
Soma, Masayoshi

Publication type:

Article

Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker.

Published in:

Heart & Vessels, 2013, v. 28, n. 1, p. 7, doi. 10.1007/s00380-011-0204-7

By:

Ishibashi, Ken;
Kurisu, Satoshi;
Kato, Yasuko;
Mitsuba, Naoya;
Dohi, Yoshihiro;
Nishioka, Kenji;
Kihara, Yasuki

Publication type:

Article

Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.

Published in:

Journal of Pharmacy & Pharmacology, 2012, v. 64, n. 6, p. 862, doi. 10.1111/j.2042-7158.2012.01508.x

By:

Elrashidy, Rania A.;
Asker, Mervat E.;
Mohamed, Hoda E.

Publication type:

Article

Renin–Angiotensin System Blocking Drugs.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2014, v. 19, n. 1, p. 14, doi. 10.1177/1074248413501018

By:

Robles, Nicolás Roberto;
Cerezo, Isis;
Hernandez-Gallego, Roman

Publication type:

Article

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF ALISKIREN IN BULK AND PHARMACEUTICAL DOSAGE FORMS.

Published in:

International Journal of Chemical & Pharmaceutical Analysis, 2015, v. 2, n. 4, p. 1

By:

Gupta, Krishna R.;
Kale, Kiran N.

Publication type:

Article

Vitamin D Regulates the Expressions of AQP-1 and AQP-4 in Mice Kidneys.

Published in:

BioMed Research International, 2019, p. 1, doi. 10.1155/2019/3027036

By:

Fu, Yu;
Zhu, Jiajun;
Zhang, Yalin;
Liu, Zuwang;
Su, Han;
Kong, Juan

Publication type:

Article

Aliskiren Improves Ischemia- and Oxygen Glucose Deprivation-Induced Cardiac Injury through Activation of Autophagy and AMP-Activated Protein Kinase.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00819

By:

Ming-Hsien Chiang;
Chan-Jung Liang;
Chen-Wei Liu;
Bo-Jhih Pan;
Wen-Ping Chen;
Yi-Fan Yang;
I-Ta Lee;
Jaw-Shiun Tsai;
Chiang-Wen Lee;
Yuh-Lien Chen

Publication type:

Article

Applicability of Vasopressor Trials in Adult Critical Care: A Prospective Multicentre Meta-Epidemiologic Cohort Study.

Published in:

Clinical Epidemiology, 2022, v. 14, p. 1087, doi. 10.2147/CLEP.S372340

By:

Buchtele, Nina;
Schwameis, Michael;
Roth, Dominik;
Schwameis, Franz;
Kraft, Felix;
Ullrich, Roman;
Mühlbacher, Jakob;
Laggner, Roberta;
Gamper, Gunnar;
Semmler, Georg;
Schoergenhofer, Christian;
Staudinger, Thomas;
Herkner, Harald

Publication type:

Article

Compliance to hypertensive prescribing guidelines and blood pressure control in elderly patients in Namibia: findings and implications.

Published in:: Journal of Pharmaceutical Health Services Research, 2021, v. 12, n. 1, p. 53, doi. 10.1093/jphsr/rmaa017
Publication type:: Article

Bevacizumab-induced proteinuria and its association with antihypertensive drugs: A retrospective cohort study using a Japanese administrative database.

Published in:

PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0289950

By:

Kiyomi, Anna;
Koizumi, Fukiko;
Imai, Shinobu;
Yamana, Hayato;
Horiguchi, Hiromasa;
Fushimi, Kiyohide;
Sugiura, Munetoshi

Publication type:

Article

Protective Effect of Aliskiren in Experimental Ischemic Stroke: Up-Regulated p-PI3K, p-AKT, Bcl-2 Expression, Attenuated Bax Expression.

Published in:

Neurochemical Research, 2016, v. 41, n. 9, p. 2300, doi. 10.1007/s11064-016-1944-7

By:

Miao, Jiangyong;
Wang, Lina;
Zhang, Xiangjian;
Zhu, Chunhua;
Cui, Lili;
Ji, Hui;
Liu, Ying;
Wang, Xiaolu

Publication type:

Article

Aliskiren and ACEIs/ARBs don't mix.

Published in:: OB/GYN Clinical Alert, 2012, p. 2
Publication type:: Article

Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.

Published in:: Current Medical Literature: Cardiology, 2010, v. 29, n. 4, p. 116
Publication type:: Article

Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 587, doi. 10.1007/s10557-020-07002-z

By:

Zhao, Zhiqiang;
Li, Ruiling;
Wang, Xinghua;
Li, Jian;
Yuan, Meng;
Liu, Enzhao;
Liu, Tong;
Li, Guangping

Publication type:

Article

The use of aliskiren as an antifibrotic drug in experimental models: A systematic review.

Published in:

Drug Development Research, 2020, v. 81, n. 1, p. 114, doi. 10.1002/ddr.21610

By:

Altarejo Marin, Thainá;
Machado Bertassoli, Bruno;
Alves de Siqueira de Carvalho, Alzira;
Feder, David

Publication type:

Article

Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing.

Published in:

Molecules, 2022, v. 27, n. 15, p. 4828, doi. 10.3390/molecules27154828

By:

Kunamaneni, Priyanka;
Kovvasu, Surya;
Yeung, Steven;
Wang, Jeffrey;
Shah, Salim;
Betageri, Guru

Publication type:

Article

Estimating the Solubility, Solution Thermodynamics, and Molecular Interaction of Aliskiren Hemifumarate in Alkylimidazolium Based Ionic Liquids.

Published in:

Molecules, 2019, v. 24, n. 15, p. 2807, doi. 10.3390/molecules24152807

By:

Anwer, Md. Khalid;
Muqtader, Mohammad;
Iqbal, Muzaffar;
Ali, Raisuddin;
Almutairy, Bjad K.;
Alshetaili, Abdullah;
Alshahrani, Saad M.;
Aldawsari, Mohammed F.;
Alalaiwe, Ahmed;
Shakeel, Faiyaz

Publication type:

Article

Protective Effects of Nanoparticle-Loaded Aliskiren on Cardiovascular System in Spontaneously Hypertensive Rats.

Published in:

Molecules, 2019, v. 24, n. 15, p. 2710, doi. 10.3390/molecules24152710

By:

Pechanova, Olga;
Barta, Andrej;
Koneracka, Martina;
Zavisova, Vlasta;
Kubovcikova, Martina;
Klimentova, Jana;
Tӧrӧk, Jozef;
Zemancikova, Anna;
Cebova, Martina;
Cicha, Iwona;
Dézsi, László;
Azzawi, May

Publication type:

Article

Hypertension.

Published in:: Nephrology Dialysis Transplantation, 2012, v. 27, n. suppl_2, p. ii26, doi. 10.1093/ndt/gfs188
Publication type:: Article

Aliskiren and valsartan in combination is a promising therapy for hypertensive renal injury in rats.

Published in:

Clinical & Experimental Hypertension, 2018, v. 40, n. 6, p. 560, doi. 10.1080/10641963.2017.1407333

By:

Abdel Kawy, Hala Salah

Publication type:

Article

Effects of aliskiren on blood pressure and humoral factors in hypertensive hemodialysis patients previously on angiotensin II receptor antagonists.

Published in:

Clinical & Experimental Hypertension, 2014, v. 36, n. 7, p. 497, doi. 10.3109/10641963.2013.863323

By:

Ito, Takayasu;
Ishikawa, Eiji;
Fujimoto, Naoki;
Okubo, Setsuya;
Ito, Goro;
Ichikawa, Takehiko;
Nomura, Shinsuke;
Ito, Masaaki

Publication type:

Article

Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy on Hemodialysis.

Published in:

Clinical & Experimental Hypertension, 2013, v. 35, n. 4, p. 244, doi. 10.3109/10641963.2013.780066

By:

Takenaka, Tsuneo;
Okayama, Mika;
Kojima, Eriko;
Nodaira, Yuka;
Arai, Jonde;
Uchida, Kosuke;
Kikuta, Tomohiro;
Sueyoshi, Keita;
Hoshi, Hitoshi;
Watanabe, Yusuke;
Takane, Hiroshi;
Suzuki, Hiromichi

Publication type:

Article

Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy.

Published in:

Clinical & Experimental Hypertension, 2012, v. 34, n. 4, p. 243, doi. 10.3109/10641963.2012.681080

By:

Takenaka, Tsuneo;
Nobe, Kanako;
Okayama, Mika;
Kojima, Eriko;
Nodaira, Yuka;
Sueyoshi, Keita;
Hoshi, Hitoshi;
Watanabe, Yusuke;
Takane, Hiroshi;
Suzuki, Hiromichi

Publication type:

Article

Epidemiology and Management of Hypertension in the Hispanic Population.

Published in:

American Journal of Cardiovascular Drugs, 2012, v. 12, n. 3, p. 165, doi. 10.2165/11631520-000000000-00000

By:

Guzman, Nicolas J.

Publication type:

Article

Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 327, doi. 10.2165/11591970-000000000-00000

By:

Drummond, W.;
Sirenko, Y. M.;
Ramos, E.;
Baek, I.;
Keefe, D. L.

Publication type:

Article

The Role of Direct Renin Inhibition in Clinical Practice: Focus on Combination Therapy.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 303, doi. 10.2165/11594140-000000000-00000

By:

Rashid, Haroon-Ur;
Mende, Christian

Publication type:

Article

Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 1, p. 21, doi. 10.2165/11586570-000000000-00000

By:

Joanne Chang;
Weiyi Yang;
Kahler, Kristijan H.;
Fellers, Thomas;
Orloff, John;
Bensimon, Arielle G.;
Yu, Andrew P.;
Fan, Chun-Po Steve;
Wu, Eric Q.

Publication type:

Article

Aliskiren in the Management of Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 6, p. 349, doi. 10.2165/11584980-000000000-00000

By:

Barrios, Vivencio;
Escobar, Carlos

Publication type:

Article

Meeting Coverage. Aliskiren + losartan may lower UACR equally across different levels of albuminuria.

Published in:

2011

By:

Meszaros, Liz

Publication type:

Proceeding

Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 4, p. 450, doi. 10.1111/1440-1681.12550

By:

Gu, Yue;
Tang, Xin;
Xie, Liping;
Meng, Guoliang;
Ji, Yong

Publication type:

Article

Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release.

Published in:

Frontiers in Physiology, 2019, p. 1, doi. 10.3389/fphys.2019.01157

By:

Hu, Shan;
Xie, Haixia;
Luo, Renfei;
Feng, Pinning;
Liu, Qiaojuan;
Han, Mengke;
Kong, Yonglun;
Zou, Xuenong;
Wang, Weidong;
Li, Chunling

Publication type:

Article

Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release.

Published in:

Frontiers in Physiology, 2019, p. 1, doi. 10.3389/fphys.2019.01157

By:

Hu, Shan;
Xie, Haixia;
Luo, Renfei;
Feng, Pinning;
Liu, Qiaojuan;
Han, Mengke;
Kong, Yonglun;
Zou, Xuenong;
Wang, Weidong;
Li, Chunling

Publication type:

Article

ICH GUIDELINE PRACTICE: A VALIDATED STABILITY INDICATING RP-UPLC METHOD DEVELOPMENT AND ITS APPLICATION FOR DETERMINATION OF ALISKIREN AND AMLODIPINE IN BULK AND FORMULATION.

Published in:

Rasayan Journal of Chemistry, 2018, v. 11, n. 3, p. 1300, doi. 10.31788/RJC.2018.1133085

By:

Vasavidevi, Dasari;
Swarnalatha, D.;
Subbareddy, G. V.

Publication type:

Article

Aliskiren Reduces the Adrenal Zona Glomerulosa Apoptosis and Autophagy in Wistar Rats with 2K1C Hypertension.

Published in:

International Journal of Hypertension, 2020, p. 1, doi. 10.1155/2020/7684849

By:

de Matos, Veronica S.;
do Nascimento, Ana L. R.;
Pereira, Priscila G.;
Rabelo, Kíssila;
Andrade, Cherley B. V.;
Moraes, Alan C. N.;
Salata, Camila;
Araújo, Victor H. V. de O.;
Ciambarella, Bianca Torres;
Bonfim Vieira, Aline;
Alves, Luciana Lontro;
da Silva, Jemima F. R.;
de Carvalho, Jorge J.

Publication type:

Article

Aliskiren Improved the Endothelial Repair Capacity of Endothelial Progenitor Cells from Patients with Hypertension via the Tie2/PI3k/Akt/eNOS Signalling Pathway.

Published in:

Cardiology Research & Practice, 2020, p. 1, doi. 10.1155/2020/6534512

By:

Yao, Shun;
Su, Chen;
Wu, Shao-Hong;
Hu, Da-Jun;
Liu, Xing

Publication type:

Article

Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disproportionality and interaction analyses.

Published in:

Diabetology & Metabolic Syndrome, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13098-024-01570-y

By:

Sridharan, Kannan;
Sivaramakrishnan, Gowri

Publication type:

Article

Aliskiren Worsens Outcomes in High-Risk Patients with Diabetes.

Published in:

American Family Physician, 2013, v. 88, n. 5, p. 333

By:

EBELL, MARK H.

Publication type:

Article

A Stereoselective Catalytic Nitroaldol Reaction as the Key Step in a Strategy for the Synthesis of the Renin Inhibitor Aliskiren.

Published in:

European Journal of Organic Chemistry, 2015, v. 2015, n. 11, p. 2531, doi. 10.1002/ejoc.201403659

By:

Rossi, Sergio;
Benaglia, Maurizio;
Porta, Riccardo;
Cotarca, Livius;
Maragni, Paolo;
Verzini, Massimo

Publication type:

Article

New drugs and dosage forms.

Published in:: American Journal of Health-System Pharmacy, 2018, v. 75, n. 1, p. e2, doi. 10.2146/news180001
Publication type:: Article

Drug manufacturing: From synthesis to pill without pause.

Published in:: Nature, 2013, v. 502, n. 7471, p. 274, doi. 10.1038/502274d
Publication type:: Article

Aliskiren – a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS.

Published in:

Gynecological Endocrinology, 2016, v. 32, n. 8, p. 675, doi. 10.3109/09513590.2016.1153055

By:

Bayir, Yasin;
Cadirci, Elif;
Polat, Beyzagul;
Kilic Baygutalp, Nurcan;
Albayrak, Abdulmecit;
Karakus, Emre;
Un, Harun;
Keles, Mevlut Sait;
Kocak Ozgeris, Fatma Betul;
Toktay, Erdem;
Karaca, Mehmet;
Halici, Zekai

Publication type:

Article

Profibrosing Effect of Angiotensin Converting Enzyme Inhibitors in Human Lung Fibroblasts.

Published in:

2015

By:

Díaz-Piña, Gabriela;
Montes, Eduardo;
Checa, Marco;
Becerril, Carina;
García de Alba, Carolina;
Vega, Anita;
Páramo, Ignacio;
Ordoñez-Razo, Rosa;
Ruiz, Victor

Publication type:

Report

The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.

Published in:

Journal of Human Hypertension, 2015, v. 29, n. 5, p. 316, doi. 10.1038/jhh.2014.86

By:

Friedrich, S;
Zeymer, U;
Dechend, R;
Hagedorn, I;
Riemer, T;
Zemmrich, C;
Bramlage, P;
Pittrow, D;
Senges, J;
Schmieder, R E

Publication type:

Article

Renin-sensitive microRNAs correlate with atherosclerosis plaque progression.

Published in:

Journal of Human Hypertension, 2014, v. 28, n. 4, p. 251, doi. 10.1038/jhh.2013.97

By:

Deiuliis, J;
Mihai, G;
Zhang, J;
Taslim, C;
Varghese, J J;
Maiseyeu, A;
Huang, K;
Rajagopalan, S

Publication type:

Article

Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study.

Published in:

Journal of Human Hypertension, 2013, v. 27, n. 5, p. 321, doi. 10.1038/jhh.2012.42

By:

Littlejohn, T W;
Jones, S W;
Zhang, J;
Hsu, H;
Keefe, D L

Publication type:

Article

Royal Jelly and Aliskiren mutually annul their protective effects against gentamicin-induced nephrotoxicity in rats.

Published in:

Veterinary World, 2020, v. 13, n. 12, p. 2658, doi. 10.14202/vetworld.2020.2658-2662

By:

Alaraj, Mohd

Publication type:

Article

Telmisartan/hydrochlorothiazide-induced nevus-associated cutaneous melanoma: first report in the medical literature.

Published in:

Expert Review of Clinical Pharmacology, 2021, v. 14, n. 3, p. 289, doi. 10.1080/17512433.2021.1890581

By:

Tchernev, Georgi;
Patterson, James W

Publication type:

Article

Efficacy, Safety, and Tolerability of Aliskiren Monotherapy Administered With a Light Meal in Elderly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Evaluation Study.

Published in:

Journal of Clinical Pharmacology, 2012, v. 52, n. 12, p. 1901, doi. 10.1177/0091270011426432

By:

Villa, Giuseppe;
Le Breton, Stephanie;
Ibram, Ghionul;
Keefe, Deborah L.

Publication type:

Article